PUBLISHER: Grand View Research | PRODUCT CODE: 1631523
PUBLISHER: Grand View Research | PRODUCT CODE: 1631523
The global vertebroplasty and kyphoplasty needles market size is expected to reach USD 1,210.2 million in 2030 and is anticipated to grow at a CAGR of 4.9% over the forecast period. Increasing geriatric population prone to vertebral disorders and demand for minimally invasive procedures due to the fewer risks associated with them is boosting market growth.
Increase in incidence rates of injuries associated with adventure, sports, and accidents are also anticipated to boost market growth. As per the 2018, Database of the National Spinal Cord Injury, round 6.0% of new cases of spinal cord injury were reported in U.S. of which 38.0% were due to vehicle accidents and 8.0% due to sports injury.
The prevalence of vertebral compression fractures increases with age and is one of the most common sequelae of osteoporosis. There are around 7,50,000 new vertebral compression fractures every year in U.S. with resultant chronic and acute pain in over one-third of the patients with vertebral fractures.
Patients with VCFs generally experience severe back pain that may limit mobility. The vertebroplasty and balloon kyphoplasty procedures have been proven successful in restoring vertebral height and strength and are capable of reducing pain in patients. There is a high demand for the procedures as they are minimally invasive and possess low risks as compared to the larger open spinal fusion surgery.
The American Society for Bone and Mineral Research has established a Task Force to address the safety and efficacy of vertebral augmentation and other methods to treat the vertebral compression fractures as there is a lack of consent regarding the safety and efficacy of both medical procedures.